Solara Active Pharma Sciences Limited (BOM:541540)
India · Delayed Price · Currency is INR 551.50
+1.15 (0.21%)
At close: Dec 5, 2025
BOM:541540 Revenue
Solara Active Pharma Sciences had revenue of 3.14B INR in the quarter ending September 30, 2025, a decrease of -9.63%. This brings the company's revenue in the last twelve months to 12.06B, down -1.29% year-over-year. In the fiscal year ending March 31, 2025, Solara Active Pharma Sciences had annual revenue of 12.84B, down -0.40%.
Revenue (ttm)
12.06B
Revenue Growth
-1.29%
P/S Ratio
2.20
Revenue / Employee
6.79M
Employees
1,775
Market Cap
26.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.84B | -51.60M | -0.40% |
| Mar 31, 2024 | 12.89B | -1.55B | -10.73% |
| Mar 31, 2023 | 14.44B | 1.75B | 13.83% |
| Mar 31, 2022 | 12.68B | -3.49B | -21.56% |
| Mar 31, 2021 | 16.17B | 2.95B | 22.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |
Solara Active Pharma Sciences News
- 18 days ago - Solara Active Pharma’s Mangalore facility clears US FDA inspection with VAI classification - Business Upturn
- 26 days ago - Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2026 Earnings Call Highlights: Navigating ... - GuruFocus
- 26 days ago - Q2 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Solara Active Pharma shares slump nearly 9% today after reporting Q2 net loss - Business Upturn
- 7 months ago - Solara Active Pharma shares rise 4% after Ambernath facility clears USFDA inspection with zero observations - Business Upturn
- 10 months ago - Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns - Business Upturn
- 11 months ago - Solara Active Pharma Sciences announces demerger of CRAMS and Polymers business - Business Upturn
- 11 months ago - Solara Active Pharma Sciences Q3 FY25 Results: Revenue up 41.6% YoY to Rs 300.31 crore - Business Upturn